Novo Nordisk A/S Common Stock · Depreciation & Amortization

Latest reportedkr 27.16B DKKperiod endingJun 30, 2026

NVO Depreciation & Amortization · DKK (kr 520.42M → kr 27.16B)

Annual Depreciation & Amortization

High-resolution chart · PNG

NVO depreciation & amortization history

Annual fiscal periods · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Depreciation & Amortization — Annual fiscal periods (DKK)
Period ending	Depreciation & Amortization (DKK)
Dec 31, 2025	21,982,000,000
Dec 31, 2024	19,107,000,000
Dec 31, 2023	9,413,000,000
Dec 31, 2022	7,362,000,000
Dec 31, 2021	6,025,000,000
Dec 31, 2020	5,753,000,000
Dec 31, 2019	5,661,000,000
Dec 31, 2018	3,925,000,000
Dec 31, 2017	3,182,000,000
Dec 31, 2016	3,193,000,000
Dec 31, 2015	2,959,000,000
Dec 31, 2014	3,435,000,000
Dec 31, 2013	2,799,000,000
Dec 31, 2012	2,693,000,000
Dec 31, 2011	2,737,000,000
Dec 31, 2010	2,467,000,000
Dec 31, 2009	2,551,000,000
Dec 31, 2008	2,449,934,000
Dec 31, 2007	3,012,146,000
Dec 31, 2006	2,141,577,400
Dec 31, 2005	1,929,017,880
Dec 31, 2004	1,904,270,070
Dec 31, 2003	1,625,992,500
Dec 31, 2002	1,330,605,720
Dec 31, 2001	1,077,667,290
Dec 31, 2000	1,034,734,800
Dec 31, 1999	946,305,280
Dec 31, 1998	987,198,100
Dec 31, 1997	1,142,082,936
Dec 31, 1996	1,067,460,352
Dec 31, 1995	1,138,881,000
Dec 31, 1994	1,055,036,150
Dec 31, 1993	799,092,000
Dec 31, 1992	693,738,500
Dec 31, 1991	591,941,350
Dec 31, 1990	520,417,600